DIOSNA Dierks & Söhne GmbH - Granulationline CGS
The CGS concept provides optimal integration of the process steps of mixing, granulating and drying. The outlet of the mixer-granulator is directly linked to the inlet of the fluid bed dryer, eliminating long transfer pipes.
Installation expenditure for the CGS is low. Mixer and dryer are supported by one common frame which makes additional framework unnecessary.
The CGS concept can incorporate an integrated explosion protection concept. The individual processing units of mixer, wet mill and dryer will then be designed to be 12 bar pressure shock resistant.
Due to the compact installation, the floor space required by the CGS plant is very small. This fact is not only important for existing plants with limited available space, but also for new plants which allows clean room space to be reduced.
All connection lines of the CGS from feeding the mixer to discharging the dryer are integrated into the automatic cleaning system. Due to well planned accessibility of all areas the supply lines can be connected in minimal time.
Website: www.diosna.com
E-mail: info@diosna.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
